MONROVIA, Calif., Nov. 5, 2013 /PRNewswire/ -- STAAR Surgical
Company (NASDAQ: STAA), a leading developer, manufacturer and
marketer of minimally invasive ophthalmic products, today announced
that it will participate in two upcoming investor conferences to
review the Company's recent financial results and business
developments with investors and interested parties.
Barry Caldwell, President and
CEO, and Steve Brown, CFO, will
present at the Stephens Fall Investment Conference at the New York
Palace Hotel on Wednesday, November
13 at 9:00 a.m. ET.
The Company will also participate in a fireside chat at the
CanaccordGenuity Medical Technology & Diagnostics Forum in
New York at the Westin Grand
Central on Thursday, November 14,
2013 at 9:00 a.m.
ET.
STAAR will offer live webcasts of both these events on the
Company's website, www.staar.com, under Investor Information. The
Stephens presentation will include audio with slides. The
CanaccordGenuity fireside format provides audio only. An archived
replay of the both these events will be available for 90 days, also
at www.staar.com.
About STAAR Surgical
STAAR, which has been dedicated solely to ophthalmic surgery for
over 25 years, designs, develops, manufactures and markets
implantable lenses for the eye and delivery systems therefor. All
of these lenses are foldable, which permits the surgeon to insert
them through a small incision. STAAR's lens used in refractive
surgery as an alternative to LASIK is called an Implantable
Collamer® Lens or "ICL." A lens used to replace the natural lens
after cataract surgery is called an intraocular lens or "IOL." Over
375,000 Visian ICLs have been implanted to date; to learn more
about the ICL go to: www.visianinfo.com. STAAR has approximately
300 full time employees and markets lenses in over 60 countries.
Headquartered in Monrovia, CA, it
manufactures in the following locations: Nidau, Switzerland; Aliso
Viejo, CA; and Monrovia,
CA. For more information, please visit the Company's website
at www.staar.com.
Collamer® is the registered trademark for STAAR's proprietary
biocompatible collagen copolymer lens material.
CONTACT:
|
Investors
|
Media
|
|
EVC Group
|
EVC Group
|
|
Doug Sherk,
415-652-9100
|
Janine
McCargo
|
|
Leigh Salvo,
415-568-9348
|
646-688-0425
|
SOURCE STAAR Surgical Company